Iron Triangle Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-70,000
Closed -$7.04M 30
2025
Q2
$7.04M Buy
+70,000
New +$5.35M 1.08% 27
2024
Q4
Sell
-180,000
Closed -$13.1M 34
2024
Q3
$13.1M Sell
180,000
-233,196
-56% -$17.2M 1.82% 20
2024
Q2
$27.7M Buy
+413,196
New +$16M 2.81% 17

Other funds holding INSM

Iron Triangle Partners's INSM Position: Q3 2025 in Review

Iron Triangle Partners sold out of Insmed (INSM) in Q3 2025, closing a stake of 70,000 shares — an estimated $7.04M sold.

Iron Triangle Partners first reported a position in INSM in Q2 2024 and held it in 3 quarters. The position peaked at $27.7M in Q2 2024. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Iron Triangle Partners reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • Iron Triangle Partners sold 70,000 Insmed shares in Q3 2025, an estimated $7.04M.
  • Iron Triangle Partners first reported a position in Insmed in Q2 2024 and held it in 3 quarters.
  • Iron Triangle Partners's Insmed position peaked at $27.7M in Q2 2024.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Iron Triangle Partners's 13F filing for Q3 2025, filed 14 Nov 2025.